Anlotinib or Penpulimab in Combination With RAI for DTC

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The purpose of this study is to assess the efficacy and safety of anlotinib in combination with I-131 in locally advanced/metastatic differentiated thyroid cancer. Anlotinib may stop the growth of tumor cells and improve iodine uptake.
Epistemonikos ID: c70b1654765593f69c5b36fe6526e7795d68936f
First added on: May 09, 2024